TransMedics Group (TMDX)
(Delayed Data from NSDQ)
$92.08 USD
+2.83 (3.17%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $92.08 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth C Momentum C VGM
Earnings News For TMDX
-
TransMedics (TMDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
TransMedics: Q4 Earnings Snapshot
-
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
-
TransMedics: Q3 Earnings Snapshot
-
TransMedics Reports Third Quarter 2023 Financial Results
-
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
-
TransMedics Reports Second Quarter 2023 Financial Results
-
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates
-
TransMedics: Q1 Earnings Snapshot
-
TransMedics Reports First Quarter 2023 Financial Results
-
TransMedics (TMDX) Expected to Beat Earnings Estimates: Should You Buy?
-
TransMedics: Q4 Earnings Snapshot
-
TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates
-
TransMedics Reports Fourth Quarter and Full Year 2022 Financial Results
-
TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates
-
TransMedics: Q3 Earnings Snapshot
-
TransMedics Reports Third Quarter 2022 Financial Results
-
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates
-
TransMedics: Q2 Earnings Snapshot
-
TransMedics Reports Second Quarter 2022 Financial Results
-
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates
-
TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates
-
TransMedics (TMDX) Reports Q3 Loss, Lags Revenue Estimates
-
TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
TransMedics (TMDX) Reports Q2 Loss, Tops Revenue Estimates